Vaibhav Tiwari

Is CAPD a viable option for those with refractory ascites? The data suggests YES #NephTwitter #medtwitter #CAPD #RefractoryAscites #PeritonealDialysis #Dialysis

@sciqst @CNSI2026 @VinBhargava @DineshKhullar3 @smritisinha29 @CriticalCareNew @drvt87 Thankyou @sciqst Great point—this gap is multifactorial: • Hyperkalemia risk (real/perceived) ⚡ • Rise in creatinine → premature down-titration 📉 • Hypotension in advanced CKD 🩺 • Monitoringconstraints 🏥 New K⁺ binders + closer monitoring may help bridge this.

🔥Day 2️⃣ @CNSI2026 Sharp takes from Dr Sanjay Srinivasa on simplifying post-transplant immunosuppression: AAP regimen (Azathioprine + Advagraf OD + Prednisolone) → ✔️ Better adherence ✔️ Comparable graft outcomes vs BD tac ✔️ Lower infections & PTDM, stable Tac #CNSICON2026

Dr Ramesh Prasad on DGF—sharp takeaways: ⏳ DGF shapes long-term graft survival 🧊 Perfusion > hypothermia (DBD & DCD) 🫁 Oxygenation critical in DCD 🔄 Every step (donor→transport→recipient) is an intervention window #CNSICON2026 @CNSI2026 @VinBhargava @drvt87 @rajdebsaha

10 things I learned at #CNSICON2026 (Day 1) 👇 (a thread) @KatherineTuttl8 @CNSI2026 @VinBhargava @drvt87 @rajdebsaha @smritisinha29 @JasmineNephro

@sciqst @DineshKhullar3 @CNSI2026 @VinBhargava @rajdebsaha @smritisinha29 @drvt87 Absolutely—this is where the field is evolving: • 🧪 New K⁺ binders (patiromer, SZC) enabling RAASi continuation • 💊 Non-steroidal MRAs (finerenone) with lower hyperkalemia risk • 📊 AI/biomarker-driven risk prediction for early intervention • 🎯 Personalized RAASi + binder

🔥Hyponatremia made simple Dr Ajay Kher: 1️⃣ Serum Osm → hypo vs pseudo 2️⃣ Urine Osm → <100 = polydipsia, >100 = ADH present 3️⃣ Urine Na → <20 = volume depletion, >40 = SIADH 🙇‍♀️Structured thinking = faster diagnosis. #CNSICON2026 @CNSI2026 @VinBhargava @rajdebsaha @drvt87

✨ The stage is set for #CNSICON2026 The Inaugural Conference of the Critical Nephrology Society of India begins—bringing together leading minds in nephrology and critical care 🩺🌍 📍Shangri-La, Eros, New Delhi @CNSI2026 @VinBhargava @smritisinha29 @rajdebsaha @drvt87

Don't miss the prestigious Oration by Dr. D.S. Rana! 🎓✨ ​Topic: "Evolution of Critical Care Nephrology as Sub Speciality of Nephrology." ​📅 Friday, March 20th | 6:00 PM 📍 Shangri-La Eros, New Delhi ​@CNSI2026 @VinBhargava @smritisinha29 @ShreshtaT

Improving outcomes in Deceased Donor Transplantation! 🕊️🏥 ​Join us on Saturday, March 21st at 9:30 AM for expert insights on Brain Death, Donor Maintenance, and Delayed Graft Function. ​@CNSI2026 @VinBhargava @smritisinha29 @shreshthaT ​#CNSICON2026 #OrganDonation #Transplant

💉⚖️ IV Albumin in Critical Care Nephrology—refining its role in practice Don’t miss this insightful session by @VinBhargava , addressing evidence, indications & clinical nuance🩺 🗓️ 21st March ⏰ 4:30-5:00 PM 📍 Shangri-La, Eros, New Delhi @CNSI2026 @smritisinha29 @rajdebsaha

Pregnancy + AKI = double challenge 🤰⚠️ Sharp insights by Dr Spurti Javalgi & @priti899 early recognition & multidisciplinary care 👩‍⚕️👨‍⚕️ 🗓️ 21st March ⏰ 12:30–1:30 PM 📍 Shangri-La, Eros, New delhi @CNSI2026 @VinBhargava @drvt87 @rajdebsaha @smritisinha29

⚔️ Debate Alert | #CNSICON2026 🗓️ 20th March 2026 ⏰ 12:00–12:45 PM 📍 New Delhi CRRT vs SLEDD 💉⚙️ Dr Niraj Tyagi 🆚 Dr Aakash Shingada Who wins in ICU dialysis strategy? 🤔 Don’t miss the clash of perspectives! @VinBhargava @CNSI2026 @aakashshingada @sgrhindia

Our VEXUS/POCUS workshop is ready to help you master lung ultrasound, IVC assessment, and the Renal Resistive Index for early AKI detection. 🫀💦 ​Get ready for hands-on excellence at #CNSICON2026! ​@CNSI2026 @VinBhargava @smritisinha29 @shreshthaT ​#POCUS #VEXUS

🔥 🔥 2 Days to go! #CNSICON2026 Is renin the new lactate?” 🤔🧪 Dr. Rajasekara Chakravarthi discusses renin as a potential marker of perfusion & shock—could it redefine how we assess hemodynamics? ⚖️ @CNSI2026 @VinBhargava @smritisinha29 @drvt87 #CriticalCare #Nephrology

Is the "Target PTH" range in Peritoneal Dialysis a lie? 📉 59% of patients in the "ideal" PTH range actually have Adynamic Bone Disease. 🔥 Vascular calcification is driven more by inflammation than the bone-vascular axis. Check out this new webinar from ERA👇!!

ERA e-seminars🚨 Mineral and bone disorders in peritoneal dialysis patients Addressing the complexities of bone health in PD patients is vital for improving long-term outcomes 🎙️ Luciano Pereira ⚖️ Juan Miguel Díaz Tocados 👥 Gaetano Alfano & Maria Jesus Lloret

🔗 Read the full study: DOI: 10.25259/IJN_21_2025 indianjnephrol.org/is-capd-feasib…

🎯 The Verdict CAPD is a feasible & effective modality for refractory ascites in ESKD. ✅ High 1-year survival ✅ Stable Albumin ✅ Acceptable infection rates

Is CAPD a viable option for those with refractory ascites? The data suggests YES #NephTwitter #medtwitter #CAPD #RefractoryAscites #PeritonealDialysis #Dialysis